Researchers have created a new technology to measure the thickness of mucus in the airways, which could aid in monitoring…
Marisa Wexler, MS
Marisa holds a Master of Science in cellular and molecular pathology from the University of Pittsburgh, where she studied novel genetic drivers of ovarian cancer. Her areas of expertise include cancer biology, immunology, and genetics, and she has worked as a science writing and communications intern for the Genetics Society of America.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Marisa Wexler, MS
Bonnie Ramsey, MD, a pediatrician and researcher who dedicated her career to advancing care for cystic fibrosis (CF), has…
The cystic fibrosis (CF) treatment Trikafta leads to changes in airway cell gene expression, or activity, that may…
Treatment with Trikafta triggered diabetes remission in four people with cystic fibrosis (CF) at a center in Australia, with…
A study will explore why some people with cystic fibrosis (CF) respond better to Trikafta than others. The…
A high dose of vitamin D combined with inulin, a prebiotic, led to improvements in the diversity of bacteria living…
Positivo Biotechnology, a company working to develop new gene therapy technologies for cystic fibrosis (CF), has been selected as…
Even though most people with cystic fibrosis (CF) place considerable importance on being prepared in making decisions about a…
Genexys Biomed has been awarded a $320,000 grant to advance the development of a novel gene therapy for cystic…
The first cystic fibrosis (CF) patient has been dosed in Part A of a Phase 2 clinical trial in…